ArticleBMC bioinformatics2026
MAGMDA: a multi-order adaptive graph-based miRNA-disease association prediction model.
Article in BMC bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Integrated Single Cell Analysis Reveals the Transcriptional Heterogeneity of Mouse Double Negative T Cells.International journal of molecular sciences · 2026Article
- IAGRN: An Interleaved-Attention Graph Neural Network for Gene Regulatory Network Inference.International journal of molecular sciences · 2026Article
- Integrating DNA methylation biomarkers for breast cancer risk prediction using artificial intelligence.Scientific reports · 2026Article
- MV-HAGCN: Prediction of miRNA-Disease Association Based on Multi-View Hybrid Attention Graph Convolutional Network.International journal of molecular sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMicroRNAs are key biomarkers for human diseases; however, experimentally identifying miRNA-disease associations was costly and inefficient. To improve the robustness and interpretability of computational models, we developed a multi-order adaptive graph-based miRNA-disease association model (MAGMDA).
resultsMAGMDA introduced an adaptive moment-order selection mechanism and a dynamic threshold network, which replaced the fixed moment orders and manually defined thresholds commonly used in traditional high-order statistical modeling with learnable components. By integrating numerically stable high-order moment computation with cross-order attention aggregation, MAGMDA enhanced model robustness and interpretability while maintaining computational efficiency. Five-fold cross-validation on the HMDD v2.0 dataset showed that MAGMDA achieved an AUC of 93.58% and an AUPR of 93.48%. Across multiple evaluation metrics, MAGMDA outperformed representative existing methods, exhibiting particularly consistent advantages on ranking-related metrics such as the area under the receiver operating characteristic curve (AUC) and the area under the precision–recall curve (AUPR), while maintaining smaller performance variations across different cross-validation folds, indicating stable predictive ability under different data partitions. Mechanistic diagnostic analysis further verified the stable utilization of the adaptive modules across different training folds. To demonstrate biological utility, we applied MAGMDA to hepatocellular carcinoma research. Based on the model predictions and analysis of the TCGA-LIHC cohort, we constructed a seven-gene prognostic signature, which was successfully validated in independent datasets and showed strong prognostic stratification ability, highlighting its potential for clinical translation.
conclusionsMAGMDA effectively improved miRNA-disease association prediction through an adaptive multi-order moment modeling framework and, supported by systematic biological validation, provided a powerful tool for translational research from computational discovery to clinical application. The MAGMDA framework and data resources are publicly available at https://github.com/zhangclbio/MAGMDA .
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.